author-photo

Wolfram Brugger

University of Tübingen
University of Freiburg

216

Papers

12333

Citations

Citation Trend

Filter By

Papers (161) Sort By

Journal Conference Others

Industrialization of an Academic Miltenyi Prodigy-Based CAR T Process

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.

2021 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

2021 Elements
Show All
- Source
- Cite
- Save
Citations (0)
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials

2019 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (5)
Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)

2018 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd‐line therapy for relapsed and refractory multiple myeloma – a phase II trial

2017 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (11)
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy

2016 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (14)
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial

2016 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (92)
Results of the Randomized Phase II Study Decider (AMLSG 14-09) Comparing Decitabine (DAC) with or without Valproic Acid (VPA) and with or without All-Trans Retinoic Acid (ATRA) Add-on in Newly Diagnosed Elderly Non-Fit AML Patients

2016 Blood
Show All
- Source
- Cite
- Save
Citations (14)